Menu Back toV1-S3

14th DIA Japan Annual Meeting 2017

[V1-S3] Raise the Curtain of “Patient Centricity” in Japan (Part II): Learn by Trial and Error

    Session Chair(s)
      Norie  Miki-Yasuda, PhD

      Norie Miki-Yasuda, PhD

      • Head of Japan Clinical Operations Division
      • Janssen Pharmaceutical K.K., Japan
      Kaori  Muto, PhD

      Kaori Muto, PhD

      • Professor, Department of Public Policy, The Institute of Medical Science
      • The University of Tokyo, Japan
    The idea of Patient Centricity and Patient and Public Engagement are increasingly attracting interest in Japan, while their concept and idea have not been organized among various stakeholders. In this session , pharmaceutical companies will share their activities for patient centricity in clinical trials and discuss Patient Centricity and Patient and Public Engagement together with the speakers of the part 1 session.
      Andreas  Koester, MD, PhD

      Innovating with the Patient, for the Patient

      Andreas Koester, MD, PhD

      • Head of R&D Operations Innovation
      • Janssen Research & Development, LLC, United States
      Atsushi  Kitamura

      Pharma Company's Patient Centric Activities

      Atsushi Kitamura

      • Director, Clinical Operations and Compliance, Development Japan
      • Pfizer Japan Inc., Japan
      Kazuyuki  Suzuki

      Utilization of Patient Voice to Study Planning

      Kazuyuki Suzuki

      • Oncology Trial Management Group, Trial Management Department, Japan Development
      • Novartis Pharma K.K., Japan
      Jin  Higashijima, PhD

      Jin Higashijima, PhD

      • Associate Professor, Faculty of Global and Science Studies
      • Yamaguchi University, Japan
      Ikuko  Yamaguchi

      Ikuko Yamaguchi

      • Board Chairperson
      • COML, Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313